Vaccination Against Meningococcal Disease In Children And Adolescents
DOWNLOAD
Download Vaccination Against Meningococcal Disease In Children And Adolescents PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Vaccination Against Meningococcal Disease In Children And Adolescents book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page
Vaccination Against Meningococcal Disease In Children And Adolescents
DOWNLOAD
Author : Matthew Snape
language : en
Publisher:
Release Date : 2009
Vaccination Against Meningococcal Disease In Children And Adolescents written by Matthew Snape and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2009 with Communicable diseases in children categories.
Adverse Effects Of Vaccines
DOWNLOAD
Author : Institute of Medicine
language : en
Publisher: National Academies Press
Release Date : 2012-04-26
Adverse Effects Of Vaccines written by Institute of Medicine and has been published by National Academies Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2012-04-26 with Medical categories.
In 1900, for every 1,000 babies born in the United States, 100 would die before their first birthday, often due to infectious diseases. Today, vaccines exist for many viral and bacterial diseases. The National Childhood Vaccine Injury Act, passed in 1986, was intended to bolster vaccine research and development through the federal coordination of vaccine initiatives and to provide relief to vaccine manufacturers facing financial burdens. The legislation also intended to address concerns about the safety of vaccines by instituting a compensation program, setting up a passive surveillance system for vaccine adverse events, and by providing information to consumers. A key component of the legislation required the U.S. Department of Health and Human Services to collaborate with the Institute of Medicine to assess concerns about the safety of vaccines and potential adverse events, especially in children. Adverse Effects of Vaccines reviews the epidemiological, clinical, and biological evidence regarding adverse health events associated with specific vaccines covered by the National Vaccine Injury Compensation Program (VICP), including the varicella zoster vaccine, influenza vaccines, the hepatitis B vaccine, and the human papillomavirus vaccine, among others. For each possible adverse event, the report reviews peer-reviewed primary studies, summarizes their findings, and evaluates the epidemiological, clinical, and biological evidence. It finds that while no vaccine is 100 percent safe, very few adverse events are shown to be caused by vaccines. In addition, the evidence shows that vaccines do not cause several conditions. For example, the MMR vaccine is not associated with autism or childhood diabetes. Also, the DTaP vaccine is not associated with diabetes and the influenza vaccine given as a shot does not exacerbate asthma. Adverse Effects of Vaccines will be of special interest to the National Vaccine Program Office, the VICP, the Centers for Disease Control and Prevention, vaccine safety researchers and manufacturers, parents, caregivers, and health professionals in the private and public sectors.
Cdc Yellow Book 2018 Health Information For International Travel
DOWNLOAD
Author : Centers for Disease Control and Prevention CDC
language : en
Publisher: Oxford University Press
Release Date : 2017-04-17
Cdc Yellow Book 2018 Health Information For International Travel written by Centers for Disease Control and Prevention CDC and has been published by Oxford University Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2017-04-17 with Medical categories.
THE ESSENTIAL WORK IN TRAVEL MEDICINE -- NOW COMPLETELY UPDATED FOR 2018 As unprecedented numbers of travelers cross international borders each day, the need for up-to-date, practical information about the health challenges posed by travel has never been greater. For both international travelers and the health professionals who care for them, the CDC Yellow Book 2018: Health Information for International Travel is the definitive guide to staying safe and healthy anywhere in the world. The fully revised and updated 2018 edition codifies the U.S. government's most current health guidelines and information for international travelers, including pretravel vaccine recommendations, destination-specific health advice, and easy-to-reference maps, tables, and charts. The 2018 Yellow Book also addresses the needs of specific types of travelers, with dedicated sections on: · Precautions for pregnant travelers, immunocompromised travelers, and travelers with disabilities · Special considerations for newly arrived adoptees, immigrants, and refugees · Practical tips for last-minute or resource-limited travelers · Advice for air crews, humanitarian workers, missionaries, and others who provide care and support overseas Authored by a team of the world's most esteemed travel medicine experts, the Yellow Book is an essential resource for travelers -- and the clinicians overseeing their care -- at home and abroad.
Meningococcal Infections New Insights For The Healthcare Professional 2011 Edition
DOWNLOAD
Author :
language : en
Publisher: ScholarlyEditions
Release Date : 2012-01-09
Meningococcal Infections New Insights For The Healthcare Professional 2011 Edition written by and has been published by ScholarlyEditions this book supported file pdf, txt, epub, kindle and other format this book has been release on 2012-01-09 with Medical categories.
Meningococcal Infections: New Insights for the Healthcare Professional: 2011 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Meningococcal Infections in a compact format. The editors have built Meningococcal Infections: New Insights for the Healthcare Professional: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Meningococcal Infections in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Meningococcal Infections: New Insights for the Healthcare Professional: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Epidemiology And Prevention Of Vaccine Preventable Diseases 13th Edition E Book
DOWNLOAD
Author : Jennifer Hamborsky, MPH, MCHES
language : en
Publisher: Public Health Foundation
Release Date : 2015-10-19
Epidemiology And Prevention Of Vaccine Preventable Diseases 13th Edition E Book written by Jennifer Hamborsky, MPH, MCHES and has been published by Public Health Foundation this book supported file pdf, txt, epub, kindle and other format this book has been release on 2015-10-19 with Health & Fitness categories.
The Public Health Foundation (PHF) in partnership with the Centers for Disease Control and Prevention (CDC) is pleased to announce the availability of Epidemiology and Prevention of Vaccine-Preventable Diseases, 13th Edition or “The Pink Book” E-Book. This resource provides the most current, comprehensive, and credible information on vaccine-preventable diseases, and contains updated content on immunization and vaccine information for public health practitioners, healthcare providers, health educators, pharmacists, nurses, and others involved in administering vaccines. “The Pink Book E-Book” allows you, your staff, and others to have quick access to features such as keyword search and chapter links. Online schedules and sources can also be accessed directly through e-readers with internet access. Current, credible, and comprehensive, “The Pink Book E-Book” contains information on each vaccine-preventable disease and delivers immunization providers with the latest information on: Principles of vaccination General recommendations on immunization Vaccine safety Child/adult immunization schedules International vaccines/Foreign language terms Vaccination data and statistics The E-Book format contains all of the information and updates that are in the print version, including: · New vaccine administration chapter · New recommendations regarding selection of storage units and temperature monitoring tools · New recommendations for vaccine transport · Updated information on available influenza vaccine products · Use of Tdap in pregnancy · Use of Tdap in persons 65 years of age or older · Use of PCV13 and PPSV23 in adults with immunocompromising conditions · New licensure information for varicella-zoster immune globulin Contact [email protected] for more information. For more news and specials on immunization and vaccines visit the Pink Book's Facebook fan page
Pediatric Vaccines And Vaccinations
DOWNLOAD
Author : Timo Vesikari
language : en
Publisher: Springer Nature
Release Date : 2021-08-19
Pediatric Vaccines And Vaccinations written by Timo Vesikari and has been published by Springer Nature this book supported file pdf, txt, epub, kindle and other format this book has been release on 2021-08-19 with Medical categories.
This second fully updated and extended edition of the textbook serves as a highly readable guide on latest developments in vaccine development and vaccination programs in infants, children and adolescents from a European perspective. The first part of the book introduces to general vaccinology, immunization programs and formulation, effects and unwanted effects of vaccines. The second and third part provide an overview on current viral and bacterial vaccines. The fourth and last part of this book discusses new vaccines in the pipeline and gives insights into safety and regulatory matters. This second edition is extended by a whole new chapter on COVID-19 vaccines. This book serves as a reference textbook in the field and helps to standardize the information on vaccines and immunization programs in the WHO European Region.
Immunisation Against Infectious Diseases
DOWNLOAD
Author : David Salisbury
language : en
Publisher: The Stationery Office
Release Date : 2006-12-11
Immunisation Against Infectious Diseases written by David Salisbury and has been published by The Stationery Office this book supported file pdf, txt, epub, kindle and other format this book has been release on 2006-12-11 with Medical categories.
This is the third edition of this publication which contains the latest information on vaccines and vaccination procedures for all the vaccine preventable infectious diseases that may occur in the UK or in travellers going outside of the UK, particularly those immunisations that comprise the routine immunisation programme for all children from birth to adolescence. It is divided into two sections: the first section covers principles, practices and procedures, including issues of consent, contraindications, storage, distribution and disposal of vaccines, surveillance and monitoring, and the Vaccine Damage Payment Scheme; the second section covers the range of different diseases and vaccines.
Disease Control Priorities Third Edition Volume 2
DOWNLOAD
Author : Robert Black
language : en
Publisher: World Bank Publications
Release Date : 2016-04-11
Disease Control Priorities Third Edition Volume 2 written by Robert Black and has been published by World Bank Publications this book supported file pdf, txt, epub, kindle and other format this book has been release on 2016-04-11 with Medical categories.
The evaluation of reproductive, maternal, newborn, and child health (RMNCH) by the Disease Control Priorities, Third Edition (DCP3) focuses on maternal conditions, childhood illness, and malnutrition. Specifically, the chapters address acute illness and undernutrition in children, principally under age 5. It also covers maternal mortality, morbidity, stillbirth, and influences to pregnancy and pre-pregnancy. Volume 3 focuses on developments since the publication of DCP2 and will also include the transition to older childhood, in particular, the overlap and commonality with the child development volume. The DCP3 evaluation of these conditions produced three key findings: 1. There is significant difficulty in measuring the burden of key conditions such as unintended pregnancy, unsafe abortion, nonsexually transmitted infections, infertility, and violence against women. 2. Investments in the continuum of care can have significant returns for improved and equitable access, health, poverty, and health systems. 3. There is a large difference in how RMNCH conditions affect different income groups; investments in RMNCH can lessen the disparity in terms of both health and financial risk.
Serogroup C Meningococcal Conjugate Vaccines
DOWNLOAD
Author : Ameneh Khatami
language : en
Publisher:
Release Date : 2014
Serogroup C Meningococcal Conjugate Vaccines written by Ameneh Khatami and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014 with categories.
Background and Aims In the United Kingdom (UK), serogroup C meningococcal (MenC) conjugate vaccines were introduced into the routine infant immunisation schedule in 1999. Subsequently, there was a dramatic decline in the rates of MenC disease in all age groups, including un-immunised infants and adults with the establishment of herd immunity. However, as with Haemophilus influenzae type b (Hib) conjugate vaccines, there is a rapid waning of vaccine induced antibody after primary infant immunisations with MenC conjugate vaccines, associated with a decline in vaccine effectiveness beyond one year after early infant immunisation. The current schedule of MenC immunisations in the UK includes two primary doses at 3 and 4 months of age, and a booster dose of Hib-MenC-TT (tetanus toxoid) conjugate vaccine at 12 months of age. However, beyond infancy, the highest rates of meningococcal disease are seen in adolescents and young adults, who are also the drivers for transmission with the highest rates of nasopharyngeal colonisation. Thus, a series of clinical vaccine trials were carried out to evaluate the effects of different carrier proteins used, and different priming schedules of MenC conjugate vaccines on their immunogenicity and their ability to induce immune memory in infants, and the persistence of immune response following vaccination, throughout childhood. Methods The clinical trials reported here were undertaken in research sites in the UK, Canada, Poland and Malta. Immunogenicity and immune persistence was evaluated by measuring MenC serum bactericidal antibody (SBA) titres in infants and children, with serial measurements assessed over time through childhood and early adolescence. Immune memory was evaluated by measuring memory B cell responses using Enzyme-linked immunospot (ELISpot). Healthy children were invited to participate in these trials through mail-outs based on birth cohorts, as well as re-invitation of children previously enrolled in vaccine trials (for follow-on studies). Results There is a greater bactericidal antibody response following a toddler booster dose of Hib-MenC-TT in children previously primed with Hib-MenC-TT given either at the same time, or as part of a combination vaccine with concomitant diphtheria, tetanus, acellular pertussis and polio (DTPa-IPV) vaccines, than in children previously primed with MenC-CRM197 (diphtheria cross reactive material) conjugate vaccine. This is despite higher antibody levels demonstrated one month after the primary vaccines in children who had received monovalent MenC-CRM197 vaccines. These differences persist to at least 5 years of age. Serogroup-specific bactericidal antibody also wane until 5 years of age following infant immunisation with a combination serogroup A, C, W135 and Y meningococcal (MenACWY-CRM197) conjugate vaccine, most markedly against serogroup A, and least against serogroup W135. By 11 to 13 years of age the percentage of children with MenC SBA titres above the threshold for protection have declined to 15% in a cohort of children who had received a single dose of MenC conjugate vaccine as pre-schoolers, with the odds of protection falling by 23% each year following immunisation. Bactericidal antibody levels also decreased by around 8% each year following immunisation. No differences were seen in the number of memory B cells generated following either 1 or 2 primary doses of MenC-CRM197. No evidence was seen for a relationship in the number of priming doses of an antigen, and the number of antigen-specific memory B cells generated following a booster (for MenC, diphtheria and tetanus). One month following a Hib-MenC-TT booster, children primed with 1 dose MenC-TT had more MenC memory B cells than children primed with either 1 or 2 doses of MenCCRM197. Conclusions Vaccines used for infant immunisation against MenC differ in their ability to prime responses to a booster dose of Hib-MenC-TT, possibly mediated through their ability to stimulate the generation of memory B cells. The greatest antibody and memory B cell responses to MenC conjugate vaccines are associated with the use of TT carrier protein for both priming and boosting. Adequate levels of circulating bactericidal antibody cannot be maintained beyond early childhood following infant and toddler immunisation schedules, and an adolescent booster dose of MenC vaccine is necessary to maintain immunity through this critical age.
Canadian Immunization Guide
DOWNLOAD
Author : Canada. Comité consultatif national de l'immunisation
language : en
Publisher:
Release Date : 2006
Canadian Immunization Guide written by Canada. Comité consultatif national de l'immunisation and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2006 with Immunization categories.
The seventh edition of the Canadian Immunization Guide was developed by the National Advisory Committee on Immunization (NACI), with the support ofthe Immunization and Respiratory Infections Division, Public Health Agency of Canada, to provide updated information and recommendations on the use of vaccines in Canada. The Public Health Agency of Canada conducted a survey in 2004, which confi rmed that the Canadian Immunization Guide is a very useful and reliable resource of information on immunization.